Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Biosystems and Biomaterials Division

BBD's mission is to foster innovation and build confidence in quantitative biology and biomaterial measurements across government and industry in support of the bio-economy.

Welcome to the Biosystems and Biomaterials Division

BBD is focused on advancing biometrology, standards, and technologies to foster innovation and accelerate the translation and commercialization of emerging biotechnologies in support of the bioeconomy.  Working across U.S. government agencies, industry, and other partners, our multi-disciplinary teams develop foundational measurement science and tools, data-driven standards, reference materials, reference data, and protocols by integrating state-of-the-art automation, analytical methods, and ML/AI as platforms for innovation and standardization. Our work supports various sectors of the bioeconomy, including clinical diagnostics, advanced therapies, agriculture, energy, industrial biotechnology, and production of new biomaterials. Click here for an overview video of the Division.


Genetic Circuit

Engineering Biology
Rapid advances in the ability to genetically modify biological organisms have advanced a new engineering discipline, commonly referred to as synthetic biology. This approach seeks to harness the power of living systems for a variety of manufacturing applications, such as advanced therapeutics, sustainable fuels, chemical feedstocks, and advanced materials.  


Regenerative Medicine and Advanced Therapies (RMAT)
Advanced therapies are demonstrating promising clinical efficacy and could change the paradigm for treating a wide range of diseases and injuries. Clinical translation of this broad class of new therapeutics requires better defined and characterized products and more robust, reliable, and cost-effective manufacturing processes.

Breast Cancer Cells

Precision Medicine
The conventional approach to medicine is rapidly changing to a data-driven strategy in which therapies are individually targeted to a patient based on genome, physiology, environment, or lifestyle. This approach is revolutionizing health care— especially in the treatment of cancer—but its success depends on using data from bioanalytical measurements with potential wide-ranging biases and uncertainties.    


Microbial communities (microbiomes) abound everywhere, forming resilient ecological networks adapted to their environments. Research has connected the behavior of these cooperative communities to beneficial and problematic outcomes in diverse biological systems including: human health, agricultural productivity, water and food safety, waste remediation, and infrastructure corrosion.

News and Updates


Press Coverage

Making Standards Exceptional

The Scientist
Samantha Maragh has taken on the difficult challenge of standardizing assays, data norms, and terminology in the ever evolving genome editing field.

Featured Videos

WIPP - A Map App to Track Stem Cells
WIPP - A Map App to Track Stem Cells


Division Chief

Deputy Chief

NIST Fellows

Administrative Officer

Division Office Manager

IT Specialist

Division Safety Representative

Property Officer